Comparative analysis of anti-human immunodeficiency virus type 1 activities of dideoxynucleoside analogs in resting and activated peripheral blood mononuclear cells
about
In vitro anti-human immunodeficiency virus activities of Z- and E-methylenecyclopropane nucleoside analogues and their phosphoro-L-alaninate diestersIn vitro induction of human immunodeficiency virus type 1 variants resistant to 2'-beta-Fluoro-2',3'-dideoxyadenosineHuman immunodeficiency virus type 1 reverse transcriptase genotype and drug susceptibility changes in infected individuals receiving dideoxyinosine monotherapy for 1 to 2 yearsComparison of the antiviral activity of hydrophobic amino acid phosphoramidate monoesters of 2'3'-dideoxyadenosine (DDA) and 3'-azido-3'-deoxythymidine (AZT).Differential extracellular and intracellular concentrations of zidovudine and lamivudine in semen and plasma of HIV-1-infected men.Positive and negative aspects of the human immunodeficiency virus protease: development of inhibitors versus its role in AIDS pathogenesisR5 variants of human immunodeficiency virus type 1 preferentially infect CD62L- CD4+ T cells and are potentially resistant to nucleoside reverse transcriptase inhibitorsTenofovir disoproxil fumarate.A Guide to HIV-1 Reverse Transcriptase and Protease Sequencing for Drug Resistance Studies.A positively charged side chain at position 154 on the beta8-alphaE loop of HIV-1 RT is required for stable ternary complex formation.Pharmacokinetics of two common antiretroviral regimens in older HIV-infected patients: a pilot study.GRL-04810 and GRL-05010, difluoride-containing nonpeptidic HIV-1 protease inhibitors (PIs) that inhibit the replication of multi-PI-resistant HIV-1 in vitro and possess favorable lipophilicity that may allow blood-brain barrier penetration.Selective inhibition of syncytium-inducing and nonsyncytium-inducing HIV-1 variants in individuals receiving didanosine or zidovudine, respectively.An intricate Web: chemokine receptors, HIV-1 and hematopoiesis.Differential removal of thymidine nucleotide analogues from blocked DNA chains by human immunodeficiency virus reverse transcriptase in the presence of physiological concentrations of 2'-deoxynucleoside triphosphates.Genotypic and phenotypic characterization of human immunodeficiency virus type 1 variants isolated from AIDS patients after prolonged adefovir dipivoxil therapy.Nonproductive human immunodeficiency virus type 1 infection in nucleoside-treated G0 lymphocytes.Effects of zidovudine-selected human immunodeficiency virus type 1 reverse transcriptase amino acid substitutions on processive DNA synthesis and viral replication.Zidovudine, lamivudine, and abacavir have different effects on resting cells infected with human immunodeficiency virus in vitro.Mutation patterns for two flaviviruses: hepatitis C virus and GB virus C/hepatitis G virus.Pharmacokinetics of bis(t-butyl-SATE)-AZTMP, a bispivaloylthioethyl prodrug for intracellular delivery of zidovudine monophosphate, in mice.
P2860
Q28343355-5E87C87E-BF6E-4026-8F0F-DB8F1FB13EF2Q28378965-5D3247C1-95BB-433C-AA89-FFBE0B58F6CBQ28379519-EC089118-5852-4046-ABF9-ABE0298E390FQ30660532-4B4613CD-44A1-4946-AB50-28ADD563F278Q33821263-3F216CF4-0D7C-472E-8CD7-124842E91B79Q34010283-C07214AF-978D-40B2-990D-124C70FF3E4CQ34301688-313FF13B-7C0E-445D-A758-1D4EF14FEB45Q34534058-86CF8A66-747A-4AD9-87AF-61CC83303946Q35742512-89C8E1D1-5665-4F3A-9A93-B7F1CFFC5D39Q36247837-6D970D78-B913-4E16-B958-CBFA7EB32F4CQ36876279-CDA17BEE-902A-46AB-9A54-D5E0F1C9AF71Q37335823-FAB59D3B-988B-4E78-A3CD-C755D201C644Q37374348-1B3866A2-7FF4-42DB-B509-BC81931CE393Q39165952-B6F8274D-7903-4AD4-8A76-FE1FE445B948Q39475801-4BE9BCFB-0EBD-486F-B2B1-910A12C35515Q39557921-E28C1D1E-8545-4B0D-B181-35D4746E1CEEQ39595263-DCEB6413-9F5B-4108-8B25-2D94C14860AAQ39873967-EAD846D8-1AEC-4053-BBAD-A4B4CCB74D1BQ41269351-20901E4D-9CA5-4A7B-892E-F13D056AD182Q42993810-730798AF-4F2A-44DF-B8FE-182233C03A2FQ43505248-0B28E631-46EC-4293-88E5-1E716662408A
P2860
Comparative analysis of anti-human immunodeficiency virus type 1 activities of dideoxynucleoside analogs in resting and activated peripheral blood mononuclear cells
description
1995 nî lūn-bûn
@nan
1995 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Comparative analysis of anti-h ...... pheral blood mononuclear cells
@ast
Comparative analysis of anti-h ...... pheral blood mononuclear cells
@en
Comparative analysis of anti-h ...... pheral blood mononuclear cells
@nl
type
label
Comparative analysis of anti-h ...... pheral blood mononuclear cells
@ast
Comparative analysis of anti-h ...... pheral blood mononuclear cells
@en
Comparative analysis of anti-h ...... pheral blood mononuclear cells
@nl
prefLabel
Comparative analysis of anti-h ...... pheral blood mononuclear cells
@ast
Comparative analysis of anti-h ...... pheral blood mononuclear cells
@en
Comparative analysis of anti-h ...... pheral blood mononuclear cells
@nl
P2093
P2860
P356
P1476
Comparative analysis of anti-h ...... pheral blood mononuclear cells
@en
P2093
G Gosselin
J L Imbach
S Chokekijchai
T Shirasaka
P2860
P304
P356
10.1128/AAC.39.11.2555
P407
P577
1995-11-01T00:00:00Z